<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
    <channel>
                    <title>Phys.org news tagged with:antipsychotic medications</title>
            <link>https://phys.org/</link>
            <language>en-us</language>
            <description>Phys.org internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

                            <item>
                    <title>Research revealed the first-ever crystal structure of the dopamine 2 receptor bound to an antipsychotic drug</title>
                    <description>Although antipsychotic drugs are among the most widely prescribed medications, individuals with schizophrenia, bipolar disorder and autism-spectrum disorders often experience severe side effects because the drugs interact with dozens of other brain receptors. Now, scientists at the UNC School of Medicine and UC San Francisco (UCSF) have solved the first high-resolution crystal structure of the dopamine 2 receptor (DRD2) bound to the antipsychotic drug risperidone, yielding a long-awaited tool for drug developers, psychiatrists, and neuroscientists.</description>
                    <link>https://phys.org/news/2018-01-revealed-first-ever-crystal-dopamine-receptor.html</link>
                    <category>Biochemistry</category>                    <pubDate>Wed, 24 Jan 2018 13:00:04 EST</pubDate>
                    <guid isPermaLink="false">news435997373</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2018/scientificbr.jpg" width="90" height="90" />
                                    </item>
                        </channel>
</rss>